查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1672051

全球氣喘治療市場研究報告 - 產業分析、規模、佔有率、成長、趨勢和預測 2025 年至 2033 年

Global Asthma Therapeutics Market Research Report- Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033
出版日期: | 出版商: Value Market Research | 英文 140 Pages | 商品交期: 最快1-2個工作天內

價格

全球氣喘治療市場規模預計將從 2024 年的 331.9 億美元成長到 2033 年的 513.6 億美元，在 2026 年至 2033 年的預測期內，年複合成長率(CAGR) 將達到 4.97%。

受氣喘盛行率不斷上升和對有效治療方案的需求不斷增加的推動，氣喘治療市場正在經歷大幅成長。隨著人們對氣喘管理認知的提高，醫療保健提供者正專注於針對每位患者的獨特需求的個人化治療計劃。氣喘治療領域的創新，包括生物製劑和標靶治療，正在改變氣喘管理的格局，為患有嚴重且無法控制的氣喘患者帶來新的希望。智慧吸入器和數位健康解決方案的發展補充了這些進步，增強了藥物依從性和監測能力。

此外，對預防保健和早期介入的日益重視正在影響氣喘治療市場。隨著醫療保健系統優先考慮主動管理策略，對有效氣喘藥物的需求正在激增。此外，對病患教育和自我管理的日益關注使患者能夠控制自己的氣喘，從而改善治療效果並降低醫療成本。

此外，遠距醫療和遠端監控技術的興起有助於更好地管理氣喘。患者現在無需親自前往醫院即可聯繫醫療專業人員進行諮詢和跟進，從而更輕鬆地管理自己的病情。這一趨勢在新冠肺炎疫情的背景下尤其重要，遠距照護已變得至關重要。總之，氣喘治療市場將實現強勁成長，其特點是創新、注重個人化護理以及致力於改善氣喘患者的生活品質。

我們的報告經過精心製作，為客戶提供有關各個行業和市場的全面且可操作的見解。每份報告都包含幾個關鍵部分，以確保徹底了解市場格局：

市場概覽：市場的詳細介紹，包括定義、分類和行業現狀概述。

市場動態：深入分析影響市場成長的關鍵促進因素、限制因素、機會與挑戰。本節探討技術進步、監管變化和新興趨勢等因素。

細分分析：根據產品類型、應用、最終用戶和地理位置等標準將市場細分為不同的細分市場。該分析強調了每個部分的表現和潛力。

競爭格局：對主要市場參與者的全面評估，包括其市場佔有率、產品組合、策略舉措和財務表現。本節深入介紹領先公司的競爭動態和關鍵策略。

市場預測：根據歷史資料和當前市場狀況，預測特定時期內的市場規模和成長趨勢。這包括定量分析和圖形表示來說明未來的市場軌跡。

區域分析：評估不同地理區域的市場表現，確定關鍵市場和區域趨勢。這有助於了解區域市場動態和機會。

新興趨勢與機會：識別當前和新興的市場趨勢、技術創新和潛在投資領域。本節提供未來市場發展和成長前景的見解。

報告涵蓋的細分

按藥物類別

  • 聯合療法 (ICS/LABA)
  • 長效BETA受體激動劑 (LABA)
  • 短效 BETA 受體激動劑 (SABA)
  • 吸入性皮質類固醇 (ICS)
  • 口服和靜脈注射皮質類固醇
  • 白三烯調節劑
  • 其他

按治療類型

  • 長期氣喘控制藥物
  • 快速緩解（救援）藥物

依給藥途徑

  • 主題
  • 口服
  • 注射劑

按配銷通路

  • 實體店面
  • 醫院藥房
  • 電子商務

按最終用途

  • 醫院和診所
  • 門診手術中心
  • 家庭護理設置
  • 公司簡介
  • 阿斯利康
  • 勃林格殷格翰
  • 西普拉有限公司
  • 科維斯製藥
  • 葛蘭素史克公司
  • 默克公司
  • 諾華製藥公司
  • 再生元製藥公司（Regeneron Pharmaceuticals Inc.）
  • 賽諾菲
  • 梯瓦製藥工業股份有限公司
  • 以上清單可以自訂。

目錄

第 1 章：前言

  • 報告描述
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法
    • 市場研究流程
    • 市場研究方法

第 2 章：執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章：氣喘治療產業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 產業趨勢
  • 波特五力分析
  • 市場吸引力分析
    • 按藥品類別進行市場吸引力分析
    • 依治療類型進行市場吸引力分析
    • 按給藥途徑進行的市場吸引力分析
    • 按配銷通路進行市場吸引力分析
    • 按最終用途進行的市場吸引力分析
    • 市場吸引力分析：按地區

第4章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料製造商清單
    • 主要原物料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷通路發展趨勢

第 5 章：全球氣喘治療市場分析：依藥物類別

  • 按藥物類別概述
  • 按藥物類別進行的歷史和預測數據分析
  • 聯合療法 (ICS/LABA)
  • 長效BETA受體激動劑 (LABA)
  • 短效 BETA 受體激動劑 (SABA)
  • 吸入性皮質類固醇 (ICS)
  • 口服和靜脈注射皮質類固醇
  • 白三烯調節劑
  • 其他

第 6 章：全球氣喘治療市場分析：依治療類型

  • 按治療類型概述
  • 按治療類型進行的歷史和預測數據分析
  • 長期氣喘控制藥物
  • 快速緩解（救援）藥物

第 7 章：全球氣喘治療市場分析：依給藥途徑

  • 依給藥途徑概述
  • 按給藥途徑進行的歷史和預測數據分析
  • 主題
  • 口服
  • 注射劑

第 8 章：全球氣喘治療市場分析：按分銷管道

  • 按配銷通路概覽
  • 按配銷通路進行的歷史和預測資料分析
  • 實體店面
  • 醫院藥房
  • 電子商務

第 9 章：全球氣喘治療市場分析：依最終用途

  • 按最終用途概述
  • 按最終用途進行的歷史和預測數據分析
  • 醫院和診所
  • 門診手術中心
  • 家庭護理設置

第 10 章：全球氣喘治療市場分析：按地區分類

  • 區域展望
  • 介紹
  • 北美銷售分析
    • 概述、歷史和預測數據銷售分析
    • 北美各細分市場銷售分析
    • 北美各國銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概述、歷史和預測數據銷售分析
    • 歐洲各細分市場銷售分析
    • 歐洲各國銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概述、歷史和預測數據銷售分析
    • 亞太地區分部銷售分析
    • 亞太地區國家銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳洲銷售分析
    • 東南亞銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概述、歷史和預測數據銷售分析
    • 拉丁美洲各細分市場銷售分析
    • 拉丁美洲各國銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概述、歷史和預測數據銷售分析
    • 中東和非洲分部銷售分析
    • 中東和非洲國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東和非洲其他地區銷售分析

第 11 章：氣喘治療公司的競爭格局

  • 氣喘治療市場競爭
  • 夥伴關係/合作/協議
  • 合併與收購
  • 新產品發布
  • 其他進展

第 12 章：公司簡介

  • 頂級公司市佔率分析
  • 市場集中度
  • AstraZeneca
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Boehringer Ingelheim
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Cipla Ltd.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Covis Pharma
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • GSK Plc
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Merck & Co. Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Novartis Pharmaceuticals Corporation
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Regeneron Pharmaceuticals Inc.
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Sanofi
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態
  • Teva Pharmaceutical Industries Ltd
    • 公司概況
    • 公司收入
    • 產品
    • 最新動態

注意 - 在公司簡介中，財務細節和最新發展取決於可用性，對於私人公司，可能不予涵蓋

Product Code: VMR11217451

Global Asthma Therapeutics Market size is anticipated to grow from USD 33.19 Billion in 2024 to USD 51.36 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 4.97% during the forecast period of 2026 to 2033.

The asthma therapeutics market is experiencing substantial growth, driven by the increasing prevalence of asthma and the rising demand for effective treatment options. As awareness of asthma management improves, healthcare providers are focusing on personalized treatment plans that address the unique needs of each patient. Innovations in asthma therapeutics, including biologics and targeted therapies, are transforming the landscape of asthma management, offering new hope for patients with severe and uncontrolled asthma. These advancements are complemented by the development of smart inhalers and digital health solutions that enhance medication adherence and monitoring.

Moreover, the growing emphasis on preventive care and early intervention is influencing the asthma therapeutics market. As healthcare systems prioritize proactive management strategies, the demand for effective asthma medications is surging. Additionally, the increasing focus on patient education and self-management is empowering individuals to take control of their asthma, leading to improved outcomes and reduced healthcare costs.

Furthermore, the rise of telemedicine and remote monitoring technologies is facilitating better asthma management. Patients can now access healthcare professionals for consultations and follow-ups without the need for in-person visits, making it easier to manage their condition. This trend is particularly relevant in the context of the COVID-19 pandemic, where remote care has become essential. In conclusion, the asthma therapeutics market is set for robust growth, characterized by innovation, a focus on personalized care, and a commitment to improving the quality of life for asthma patients.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Drug Class

  • Combination Therapies (ICS/LABAs)
  • Long-Acting Beta Agonists (LABAs)
  • Short-Acting Beta Agonists (SABAs)
  • Inhaled Corticosteroids (ICS)
  • Oral and Intravenous Corticosteroids
  • Leukotriene Modifiers
  • Other

By Treatment Type

  • Long-Term Asthma Control Medications
  • Quick-Relief (Rescue) Medications

By Route of Administration

  • Topical
  • Oral
  • Injectables

By Distribution Channel

  • Brick & Mortar
  • Hospital Pharmacies
  • E-Commerce

By End-Use

  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Homecare Settings
  • COMPANIES PROFILED
  • AstraZeneca
  • Boehringer Ingelheim
  • Cipla Ltd.
  • Covis Pharma
  • GSK plc
  • Merck & Co. Inc.
  • Novartis Pharmaceuticals Corporation
  • Regeneron Pharmaceuticals Inc.
  • Sanofi
  • Teva Pharmaceutical Industries Ltd
  • The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. ASTHMA THERAPEUTICS INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porters Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Drug Class
    • 3.7.2 Market Attractiveness Analysis By Treatment Type
    • 3.7.3 Market Attractiveness Analysis By Route Of Administration
    • 3.7.4 Market Attractiveness Analysis By Distribution Channel
    • 3.7.5 Market Attractiveness Analysis By End-Use
    • 3.7.6 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL ASTHMA THERAPEUTICS MARKET ANALYSIS BY DRUG CLASS

  • 5.1. Overview By Drug Class
  • 5.2. Historical and Forecast Data Analysis By Drug Class
  • 5.3. Combination Therapies (ICS/LABAs) Historic and Forecast Sales By Regions
  • 5.4. Long-Acting Beta Agonists (LABAs) Historic and Forecast Sales By Regions
  • 5.5. Short-Acting Beta Agonists (SABAs) Historic and Forecast Sales By Regions
  • 5.6. Inhaled Corticosteroids (ICS) Historic and Forecast Sales By Regions
  • 5.7. Oral And Intravenous Corticosteroids Historic and Forecast Sales By Regions
  • 5.8. Leukotriene Modifiers Historic and Forecast Sales By Regions
  • 5.9. Other Historic and Forecast Sales By Regions

6. GLOBAL ASTHMA THERAPEUTICS MARKET ANALYSIS BY TREATMENT TYPE

  • 6.1. Overview By Treatment Type
  • 6.2. Historical and Forecast Data Analysis By Treatment Type
  • 6.3. Long-Term Asthma Control Medications Historic and Forecast Sales By Regions
  • 6.4. Quick-Relief (Rescue) Medications Historic and Forecast Sales By Regions

7. GLOBAL ASTHMA THERAPEUTICS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

  • 7.1. Overview By Route Of Administration
  • 7.2. Historical and Forecast Data Analysis By Route Of Administration
  • 7.3. Topical Historic and Forecast Sales By Regions
  • 7.4. Oral Historic and Forecast Sales By Regions
  • 7.5. Injectables Historic and Forecast Sales By Regions

8. GLOBAL ASTHMA THERAPEUTICS MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 8.1. Overview By Distribution Channel
  • 8.2. Historical and Forecast Data Analysis By Distribution Channel
  • 8.3. Brick & Mortar Historic and Forecast Sales By Regions
  • 8.4. Hospital Pharmacies Historic and Forecast Sales By Regions
  • 8.5. E-Commerce Historic and Forecast Sales By Regions

9. GLOBAL ASTHMA THERAPEUTICS MARKET ANALYSIS BY END-USE

  • 9.1. Overview By End-Use
  • 9.2. Historical and Forecast Data Analysis By End-Use
  • 9.3. Hospitals & Clinics Historic and Forecast Sales By Regions
  • 9.4. Ambulatory Surgical Centers Historic and Forecast Sales By Regions
  • 9.5. Homecare Settings Historic and Forecast Sales By Regions

10. GLOBAL ASTHMA THERAPEUTICS MARKET ANALYSIS BY GEOGRAPHY

  • 10.1. Regional Outlook
  • 10.2. Introduction
  • 10.3. North America Sales Analysis
    • 10.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.3.2 North America By Segment Sales Analysis
    • 10.3.3 North America By Country Sales Analysis
    • 10.3.4 United States Sales Analysis
    • 10.3.5 Canada Sales Analysis
    • 10.3.6 Mexico Sales Analysis
  • 10.4. Europe Sales Analysis
    • 10.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.4.2 Europe By Segment Sales Analysis
    • 10.4.3 Europe By Country Sales Analysis
    • 10.4.4 United Kingdom Sales Analysis
    • 10.4.5 France Sales Analysis
    • 10.4.6 Germany Sales Analysis
    • 10.4.7 Italy Sales Analysis
    • 10.4.8 Russia Sales Analysis
    • 10.4.9 Rest Of Europe Sales Analysis
  • 10.5. Asia Pacific Sales Analysis
    • 10.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.5.2 Asia Pacific By Segment Sales Analysis
    • 10.5.3 Asia Pacific By Country Sales Analysis
    • 10.5.4 China Sales Analysis
    • 10.5.5 India Sales Analysis
    • 10.5.6 Japan Sales Analysis
    • 10.5.7 South Korea Sales Analysis
    • 10.5.8 Australia Sales Analysis
    • 10.5.9 South East Asia Sales Analysis
    • 10.5.10 Rest Of Asia Pacific Sales Analysis
  • 10.6. Latin America Sales Analysis
    • 10.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.6.2 Latin America By Segment Sales Analysis
    • 10.6.3 Latin America By Country Sales Analysis
    • 10.6.4 Brazil Sales Analysis
    • 10.6.5 Argentina Sales Analysis
    • 10.6.6 Peru Sales Analysis
    • 10.6.7 Chile Sales Analysis
    • 10.6.8 Rest of Latin America Sales Analysis
  • 10.7. Middle East & Africa Sales Analysis
    • 10.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 10.7.2 Middle East & Africa By Segment Sales Analysis
    • 10.7.3 Middle East & Africa By Country Sales Analysis
    • 10.7.4 Saudi Arabia Sales Analysis
    • 10.7.5 UAE Sales Analysis
    • 10.7.6 Israel Sales Analysis
    • 10.7.7 South Africa Sales Analysis
    • 10.7.8 Rest Of Middle East And Africa Sales Analysis

11. COMPETITIVE LANDSCAPE OF THE ASTHMA THERAPEUTICS COMPANIES

  • 11.1. Asthma Therapeutics Market Competition
  • 11.2. Partnership/Collaboration/Agreement
  • 11.3. Merger And Acquisitions
  • 11.4. New Product Launch
  • 11.5. Other Developments

12. COMPANY PROFILES OF ASTHMA THERAPEUTICS INDUSTRY

  • 12.1. Top Companies Market Share Analysis
  • 12.2. Market Concentration Rate
  • 12.3. AstraZeneca
    • 12.3.1 Company Overview
    • 12.3.2 Company Revenue
    • 12.3.3 Products
    • 12.3.4 Recent Developments
  • 12.4. Boehringer Ingelheim
    • 12.4.1 Company Overview
    • 12.4.2 Company Revenue
    • 12.4.3 Products
    • 12.4.4 Recent Developments
  • 12.5. Cipla Ltd.
    • 12.5.1 Company Overview
    • 12.5.2 Company Revenue
    • 12.5.3 Products
    • 12.5.4 Recent Developments
  • 12.6. Covis Pharma
    • 12.6.1 Company Overview
    • 12.6.2 Company Revenue
    • 12.6.3 Products
    • 12.6.4 Recent Developments
  • 12.7. GSK Plc
    • 12.7.1 Company Overview
    • 12.7.2 Company Revenue
    • 12.7.3 Products
    • 12.7.4 Recent Developments
  • 12.8. Merck & Co. Inc.
    • 12.8.1 Company Overview
    • 12.8.2 Company Revenue
    • 12.8.3 Products
    • 12.8.4 Recent Developments
  • 12.9. Novartis Pharmaceuticals Corporation
    • 12.9.1 Company Overview
    • 12.9.2 Company Revenue
    • 12.9.3 Products
    • 12.9.4 Recent Developments
  • 12.10. Regeneron Pharmaceuticals Inc.
    • 12.10.1 Company Overview
    • 12.10.2 Company Revenue
    • 12.10.3 Products
    • 12.10.4 Recent Developments
  • 12.11. Sanofi
    • 12.11.1 Company Overview
    • 12.11.2 Company Revenue
    • 12.11.3 Products
    • 12.11.4 Recent Developments
  • 12.12. Teva Pharmaceutical Industries Ltd
    • 12.12.1 Company Overview
    • 12.12.2 Company Revenue
    • 12.12.3 Products
    • 12.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Drug Class (USD MN)
  • Combination Therapies (ICS/LABAs) Market Sales By Geography (USD MN)
  • Long-Acting Beta Agonists (LABAs) Market Sales By Geography (USD MN)
  • Short-Acting Beta Agonists (SABAs) Market Sales By Geography (USD MN)
  • Inhaled Corticosteroids (ICS) Market Sales By Geography (USD MN)
  • Oral And Intravenous Corticosteroids Market Sales By Geography (USD MN)
  • Leukotriene Modifiers Market Sales By Geography (USD MN)
  • Other Market Sales By Geography (USD MN)
  • Analysis By Treatment Type (USD MN)
  • Long-Term Asthma Control Medications Market Sales By Geography (USD MN)
  • Quick-Relief (Rescue) Medications Market Sales By Geography (USD MN)
  • Analysis By Route Of Administration (USD MN)
  • Topical Market Sales By Geography (USD MN)
  • Oral Market Sales By Geography (USD MN)
  • Injectables Market Sales By Geography (USD MN)
  • Analysis By Distribution Channel (USD MN)
  • Brick & Mortar Market Sales By Geography (USD MN)
  • Hospital Pharmacies Market Sales By Geography (USD MN)
  • E-Commerce Market Sales By Geography (USD MN)
  • Analysis By End-Use (USD MN)
  • Hospitals & Clinics Market Sales By Geography (USD MN)
  • Ambulatory Surgical Centers Market Sales By Geography (USD MN)
  • Homecare Settings Market Sales By Geography (USD MN)
  • Global Asthma Therapeutics Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Asthma Therapeutics Report
  • Market Research Process
  • Market Research Methodology
  • Global Asthma Therapeutics Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Drug Class
  • Market Attractiveness Analysis By Treatment Type
  • Market Attractiveness Analysis By Route Of Administration
  • Market Attractiveness Analysis By Distribution Channel
  • Market Attractiveness Analysis By End-Use
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Drug Class (USD MN)
  • Combination Therapies (ICS/LABAs) Market Sales By Geography (USD MN)
  • Long-Acting Beta Agonists (LABAs) Market Sales By Geography (USD MN)
  • Short-Acting Beta Agonists (SABAs) Market Sales By Geography (USD MN)
  • Inhaled Corticosteroids (ICS) Market Sales By Geography (USD MN)
  • Oral And Intravenous Corticosteroids Market Sales By Geography (USD MN)
  • Leukotriene Modifiers Market Sales By Geography (USD MN)
  • Other Market Sales By Geography (USD MN)
  • Global Market Analysis By Treatment Type (USD MN)
  • Long-Term Asthma Control Medications Market Sales By Geography (USD MN)
  • Quick-Relief (Rescue) Medications Market Sales By Geography (USD MN)
  • Global Market Analysis By Route Of Administration (USD MN)
  • Topical Market Sales By Geography (USD MN)
  • Oral Market Sales By Geography (USD MN)
  • Injectables Market Sales By Geography (USD MN)
  • Global Market Analysis By Distribution Channel (USD MN)
  • Brick & Mortar Market Sales By Geography (USD MN)
  • Hospital Pharmacies Market Sales By Geography (USD MN)
  • E-Commerce Market Sales By Geography (USD MN)
  • Global Market Analysis By End-Use (USD MN)
  • Hospitals & Clinics Market Sales By Geography (USD MN)
  • Ambulatory Surgical Centers Market Sales By Geography (USD MN)
  • Homecare Settings Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis
  • Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.